Literature DB >> 27752397

Hypercalcemia as Initial Presentation of Metastatic Adenocarcinoma of Gastric Origin: A Case Report and Review of the Literature.

Mehandar Kumar1, Abhishek Kumar1, Vinod Kumar1, Supreet Kaur1, Michael Maroules1.   

Abstract

Hypercalcemia of malignancy due to metastatic gastric adenocarcinoma is extremely rare; in fact, to the best of our knowledge, only three case reports of hypercalcemia associated with metastatic gastric adenocarcinoma have been published in the literature to date. Herein, we report a rare case involving a 61-year-old African-American female who had hypercalcemia at initial presentation and who was later diagnosed with poorly differentiated gastric adenocarcinoma with extensive liver metastases, without bone involvement. She was found to have elevated parathyroid hormone-related peptide and normal parathyroid hormone levels. Despite aggressive treatment, she died within a few months of diagnosis.

Entities:  

Keywords:  Humoral hypercalcemia of malignancy; Metastatic gastric adenocarcinoma; Neoplosm metastasis; Parathyroid hormone-related peptide

Year:  2016        PMID: 27752397      PMCID: PMC5065949          DOI: 10.5230/jgc.2016.16.3.191

Source DB:  PubMed          Journal:  J Gastric Cancer        ISSN: 1598-1320            Impact factor:   3.720


  13 in total

1.  Expression of parathyroid hormone-related peptide (PTHrP) in gastric tumours.

Authors:  G K Alipov; M Ito; M Nakashima; Y Ikeda; T Nakayama; A Ohtsuru; S Yamashita; I Sekine
Journal:  J Pathol       Date:  1997-06       Impact factor: 7.996

Review 2.  Clinical practice. Hypercalcemia associated with cancer.

Authors:  Andrew F Stewart
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

3.  Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.

Authors:  Mara J Horwitz; Mary Beth Tedesco; Susan M Sereika; Bruce W Hollis; Adolfo Garcia-Ocaña; Andrew F Stewart
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.

Authors:  Chris Deans; Stephen Wigmore; Simon Paterson-Brown; James Black; James Ross; Kenneth C H Fearon
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

5.  Hypercalcemia of cancer in the digestive tract.

Authors:  S Monno; A Nagata; S Furuta
Journal:  J Clin Gastroenterol       Date:  1987-02       Impact factor: 3.062

6.  Parathyroid hormone-related peptide and survival of patients with cancer and hypercalcemia.

Authors:  Ngoc Uyen Truong; Michael D deB Edwardes; Vasilios Papavasiliou; David Goltzman; Richard Kremer
Journal:  Am J Med       Date:  2003-08-01       Impact factor: 4.965

7.  Parathyroid hormone-related protein expression in human gastric adenocarcinomas not associated with hypercalcemia.

Authors:  O Abdeen; S J Pandol; D W Burton; L J Deftos
Journal:  Am J Gastroenterol       Date:  1995-10       Impact factor: 10.864

8.  Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center.

Authors:  R Vassilopoulou-Sellin; B M Newman; S H Taylor; V F Guinee
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

9.  Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia.

Authors:  K Nakayama; S Fukumoto; S Takeda; Y Takeuchi; T Ishikawa; M Miura; K Hata; M Hane; Y Tamura; Y Tanaka; M Kitaoka; T Obara; E Ogata; T Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

Review 10.  Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.

Authors:  Koji Nakajima; Masataka Tamai; Shinji Okaniwa; Yoshiyuki Nakamura; Mutsuhiro Kobayashi; Tomohiro Niwa; Naoto Horigome; Nobuo Ito; Satoru Suzuki; Shinichi Nishio; Mitsuhisa Komatsu
Journal:  Endocr J       Date:  2013-01-09       Impact factor: 2.349

View more
  1 in total

1.  Prognostic factors for survival in patients with gastric adenocarcinoma.

Authors:  Piyakorn Poonyam; Natsuda Aumpan; Ratha-Korn Vilaichone
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.